Live tape
Top 8, mentions 7d10,776GOOGL2,063 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,494 mentions▲ +0.08NBIS1,420 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,189 mentions▲ +0.08META1,016 mentions▲ +0.03MSFT839 mentions▲ +0.06

Equity · Healthcare

ACAD

ACADIA Pharmaceuticals Inc. · NasdaqGS

$29.02 +3.64% 1D Finazon · prior-day close · Aug 17, 2026

Reddit mentioned ACAD 1 times in the 30 days to 18 August 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 18 August 2026.

Price · Chart
Our own end-of-day closes 61 sessions
$30.0 $20.0 20 May 17 Aug

The line runs $20.94 on 20 May through $29.02 on 17 August, on a scale from $20.0 to $30.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of ACAD over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $20.94 on 20 May 2026 through $29.02 on 17 August 2026.

Market cap $5.0B
P/E (TTM) 37.2
52-week range $20 – $29.46
Avg volume 340.9K
Mentions · 30d 1

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

ACAD · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Day4 Aug 2026

MENTIONS10–2 / day
PRICE$27$24–$30Source: Finazon
ACAD over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for. A dashed lead-in along the baseline marks days before our record of this entity starts on 4 August 2026; it is not a run of zeroes.per day012usd$24$26$28$3020 Jul27 Jul4 Aug11 Aug18 Aug
ACAD over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for. A dashed lead-in along the baseline marks days before our record of this entity starts on 4 August 2026; it is not a run of zeroes.20 Jul4 Aug18 Aug

Before our first record — not zero

The Distributed Sentinel 18 Aug 2026

ACAD drew 1 Reddit mentions over the 30 days to 18 August 2026

This chart in words

The chart plots daily Reddit mentions of ACAD over the 30 days to 18 August 2026: 1 in total, busiest on 4 August with 1, and 1 on the last day counted. We hold no record of ACAD before 4 August 2026, so the dashed lead-in marks days this chart cannot describe: neither a run of zeroes nor a claim about when we started counting. The line is the daily close over the same window: $25.08 on 20 July, $29.02 on 17 August. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Finazon · prior-day close, some closes dollar-rounded at the source

Crowd sentiment on ACAD · 30d

n = 1 scored · Method

1 mention of ACAD was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where ACAD is discussed

(30d)
r/stocks 100% 1 +0.05

ACAD insider trades

SEC Form 4 · last 90 days · newest reported trade 6 Aug 2026
Open-market buys 0
Open-market sells 5
Net sold $1.43M
Non-trade filings 9
Date Insider Type Shares Value
06 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Sell 14,292 $418K
05 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Sell 5,849 $170K
30 Jul 2026 Thompson Elizabeth H.Z. EVP, Head of Research & Dev Sell 16,558 $433K
26 Jun 2026 Kihara James PRINCIPAL ACCOUNTING OFFICER Sell 11,421 $298K
26 May 2026 Kihara James PRINCIPAL ACCOUNTING OFFICER Sell 5,401 $114K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
06 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Option exercise 14,292 $255K
05 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Option exercise 5,849 $104K
29 Jul 2026 Thompson Elizabeth H.Z. EVP, Head of Research & Dev Option exercise 32,272
29 May 2026 HARRIGAN EDMUND Director Option exercise 8,107
29 May 2026 Brege Laura Director Option exercise 8,107
29 May 2026 Daly James M Director Option exercise 8,107
29 May 2026 Poole Jonathan Director Option exercise 2,010
29 May 2026 GAROFALO ELIZABETH A. Director Option exercise 8,107
29 May 2026 Ndu Adora Director Option exercise 8,107

ACAD reported financials

SEC EDGAR XBRL

ACAD reported revenue of $1.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was $391.0M.

Figure Reported Period
Revenue $1.1B 31 Dec 2025 fiscal year
Net income $391.0M 31 Dec 2025 fiscal year
Diluted EPS $2.30 31 Dec 2025 fiscal year
Total assets $1.7B 30 Jun 2026 at period end
Total equity $1.3B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

ACAD earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.18 —
31 Mar 2026 Q1 2026 $0.02 —
31 Dec 2025 FY 2025 $2.30 —
30 Sep 2025 Q3 2025 $0.42 —
30 Jun 2025 Q2 2025 $0.16 —
31 Mar 2025 Q1 2025 $0.11 —
31 Dec 2024 FY 2024 $1.36 —
30 Sep 2024 Q3 2024 $0.20 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ACAD institutional holders

SEC Form 13F

13 of the 45 institutional funds we track reported a ACAD position for the quarter ended 30 Jun 2026 — a combined $1.4B; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) +0.0% shares 42,912,904 $1.1B
Point72 Asset Management Held (±25%) −5.6% shares 2,433,168 $61.6M
Citadel Advisors Added +250.4% shares 2,182,177 $55.2M
Marshall Wace Added +2,216.5% shares 1,764,838 $44.7M
D. E. Shaw & Co. Added +132.6% shares 1,697,937 $43.0M
Renaissance Technologies Trimmed −25.6% shares 1,282,596 $32.4M
Two Sigma Investments Held (±25%) +19.6% shares 926,992 $23.5M
Fisher Asset Management Held (±25%) −4.6% shares 699,230 $17.7M
Millennium Management Held (±25%) −16.4% shares 589,924 $14.9M
AQR Capital Management Held (±25%) −1.0% shares 522,749 $13.2M

Showing the 10 largest of 13 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

ACAD fails-to-deliver

SEC CNS data

On 20 Jul 2026, 4,182 shares of ACAD failed to deliver (about $107K).

Settlement date Shares failed Notional % of shares out
20 Jul 2026 4,182 $107K 0.002%
16 Jul 2026 389 $10K <0.001%

Source: SEC fails-to-deliver (CNS) data

ACAD — frequently asked questions

From live data

Is Reddit bullish or bearish on ACAD?

Across 1 classified ACAD mentions in the last 30 days, 100% read bullish, 0% bearish and 0% neutral. Crowd sentiment is a social signal, not investment advice.

When did ACAD last report earnings?

ACADIA Pharmaceuticals (ACAD) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are ACAD insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 5 sells by ACAD insiders on the open market. A further 9 filings were grants, awards, gifts or exercises rather than open-market trades.

What exchange is ACAD listed on?

ACADIA Pharmaceuticals trades on NASDAQ under the ticker ACAD.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.